Takeda launches mobile application to support the patient for treatment of genetic diseases

Takeda launches mobile application to support the patient for treatment of genetic diseases

The XPERT EASE App will support HCPs with dose calculation for the treatment of patients with  Lysosomal Storage Disorders Takeda India, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, launched the 'XPERT EASE' application. The application is developed for the exclusive use of healthcare professionals…
Takeda Named Top Employer in India

Takeda Named Top Employer in India

Takeda also Named Global Top Employer for Fourth Year Running Takeda India has been named a Top Employer in 2021 by Top Employers Institute. This is also the fourth year in a row Takeda has received the prestigious global Top Employer® status. Takeda also received four regional certifications for Asia Pacific,…
Takeda India Strengthens Patient Offering via Availability of Vedolizumab

Takeda India Strengthens Patient Offering via Availability of Vedolizumab

Introduces innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn's Disease. Takeda India, part of the Takeda Pharmaceutical Company Ltd., a global values-based R&D-driven biopharmaceutical leader, today announced the expansion of its highly innovative portfolio for patients in the country with the launch of Kynteles® (generic name: Vedolizumab)…
Takeda India Contributes ₹1.2Cr to COVID-19 PM Cares Fund

Takeda India Contributes ₹1.2Cr to COVID-19 PM Cares Fund

The contribution to the PM Cares Fund aims to support patients and the Government to contain the spread of the disease. Takeda India, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, has announced a donation of ₹ 1.2 Crores to the PM Cares Fund to support India's fight…